Bausch & Lomb (BLCO) Capital Expenditures (2021 - 2026)
Bausch & Lomb's (BLCO) quarterly Capital Expenditures came in at $71.0 million in Q2 2026, down 20.22% YoY from $89.0 million in Q2 2025, and down 29.0% on a QoQ basis from $100.0 million in Q1 2026.
Bausch & Lomb (BLCO) Capital Expenditures (2021 - 2026) Analysis & Trends
Bausch & Lomb (BLCO) has 6 years of Capital Expenditures data on file, last reported at $71.0 million in Q2 2026.
- Quarterly Capital Expenditures fell 20.22% year-over-year to $71.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $321.0 million (down 8.55% YoY) and the FY2025 annual result came in at $349.0 million, up 19.93% from the prior year.
- Capital Expenditures fell to $71.0 million in Q2 2026, from $100.0 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $110.0 million in Q1 2025 to a low of $27.0 million in Q2 2023.
- A 5-year average of $64.8 million and a median of $69.0 million in 2024 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2023 — Capital Expenditures plunged 32.65% — and 2024, when it surged 166.67%.
- Tracing BLCO's Capital Expenditures over 5 years: stood at $50.0 million in 2022, then soared by 68.0% to $84.0 million in 2023, then climbed by 9.52% to $92.0 million in 2024, then decreased by 17.39% to $76.0 million in 2025, then decreased by 6.58% to $71.0 million in 2026.
- The last three Capital Expenditures figures came in at $71.0 million (Q2 2026), $100.0 million (Q1 2026), and $76.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.29 Bn | 129.07 Bn | 1.96 Bn | 112.60 Mn |
| 2 | Becton Dickinson | 52.49 Bn | 51.63 Bn | 2.32 Bn | 143.00 Mn |
| 3 | Alcon | 35.74 Bn | 34.38 Bn | 1.68 Bn | 374.00 Mn |
| 4 | Resmed | 33.95 Bn | 32.48 Bn | 861.22 Mn | 51.13 Mn |
| 5 | Medline | 28.95 Bn | 26.27 Bn | 2.22 Bn | 111.00 Mn |
| 6 | West Pharmaceutical Services | 25.04 Bn | 24.60 Bn | 329.20 Mn | 43.20 Mn |
| 7 | Solventum | 15.32 Bn | 14.92 Bn | 1.29 Bn | 83.00 Mn |
| 8 | Cooper Companies | 14.85 Bn | 14.71 Bn | 735.40 Mn | 86.40 Mn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 116.00 Mn |
| 10 | Bausch & Lomb | 6.19 Bn | 5.81 Bn | 867.00 Mn | 71.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 71.00 Mn |
| Jun 30, 2026 | 71.00 Mn |
| Mar 31, 2026 | 100.00 Mn |
| Mar 31, 2026 | 100.00 Mn |
| Dec 31, 2025 | 76.00 Mn |
| Dec 31, 2025 | 76.00 Mn |
| Sep 30, 2025 | 74.00 Mn |
| Sep 30, 2025 | 74.00 Mn |
| Jun 30, 2025 | 89.00 Mn |
| Jun 30, 2025 | 89.00 Mn |
| Mar 31, 2025 | 110.00 Mn |
| Mar 31, 2025 | 110.00 Mn |
| Dec 31, 2024 | 92.00 Mn |
| Dec 31, 2024 | 92.00 Mn |
| Sep 30, 2024 | 60.00 Mn |
| Sep 30, 2024 | 60.00 Mn |
| Jun 30, 2024 | 72.00 Mn |
| Jun 30, 2024 | 72.00 Mn |
| Mar 31, 2024 | 67.00 Mn |
| Mar 31, 2024 | 67.00 Mn |